Texas Instruments Allocates $15 Million to Fund

(PresseBox) ( DALLAS, )
Texas Instruments Incorporated (TI) (NYSE: TXN) today announced that the company is allocating a total of $15 million to fund medical technology research at selected universities worldwide. The funding will support research and development of key emerging medical technologies, over a period of several years, in areas such as personal medical devices, implantables, medical imaging, wireless healthcare systems and biosensor technology.

"TI has always been at the forefront of technology research and we are very excited to partner with universities worldwide to help develop the nextgeneration of medical electronics that will allow our customers to improve the quality of healthcare and life," said Kent Novak, vice president of TI's medical business unit.

TI technology has been utilized in many recent advancements in the medical field, including portable imaging, wireless communications for patient monitoring, retinal prosthesis and DSPbased robotics to improve quality of life for amputees. TI's expertise and innovation in a broad range of semiconductor technologies - highperformance analog, digital signal processing, ultralowpower microcontrollers, wireless connectivity and DLP® - complement the demanding requirements of nextgeneration medical systems.

Novak added: "In the 1990s, wireless communications systems, cell phones and PDAs were major areas of R&D and leading market drivers in the electronics industry. An outgrowth of these developments is higher system integration and lower power requirements. Many new and emerging medical systems are now utilizing these established technologies to improve patient monitoring in hospitals, for featureenhanced personal care devices, and for rapidly modernizing healthcare systems in developing countries where standardized healthcare is virtually nonexistent."

For more information regarding this program, timing and the process for submitting proposals for medical technology research funding, please visit www.ti.com/medical. Projects will be selected by TI's Medical Business Unit.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.